Tarsus Pharmaceuticals to Report Q4 and Full Year 2025 Results

The company will host a live webcast on February 23, 2026 to discuss the financial results.

Published on Feb. 20, 2026

Got story updates? Submit your updates here. ›

Tarsus Pharmaceuticals, Inc., a pharmaceutical company, announced that it will host a live webcast on Monday, February 23, 2026 at 1:30 p.m. PT / 4:30 p.m. ET to report its fourth quarter and full year 2025 financial results.

Why it matters

As a publicly traded pharmaceutical company, Tarsus Pharmaceuticals' quarterly and annual financial results are closely watched by investors to gauge the company's performance and growth prospects.

The details

The webcast will provide an overview of Tarsus Pharmaceuticals' financial results for the fourth quarter and full year 2025, including details on revenue, expenses, and other key metrics that reflect the company's operational and financial health.

  • Tarsus Pharmaceuticals will host the webcast on Monday, February 23, 2026.
  • The webcast will take place at 1:30 p.m. PT / 4:30 p.m. ET.

The players

Tarsus Pharmaceuticals, Inc.

A pharmaceutical company that develops and commercializes innovative therapies for eye diseases and other medical conditions.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be able to access the webcast and review the financial results in detail, which may inform their investment decisions and assessments of the company's future prospects.

The takeaway

Tarsus Pharmaceuticals' upcoming financial report will provide valuable insights into the company's performance and growth trajectory, which is of interest to investors and the broader pharmaceutical industry.